NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Octozi

Octozi

Private
New York City, New YorkEnterprise Softwarehttps://octozi.com/

Last Round

Seed

Jul 7, 2026

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Octozi is an artificial intelligence company that develops a platform to automate clinical development workflows for the pharmaceutical and biotechnology industries.

Sector

Enterprise Software

Verticals

Clinical Trials, Medical AI, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial automationclinical trial softwareAI for clinical trialsclinical data managementeClinical solutionshuman-in-the-loop AIpharma techAI agentsCRO softwareclinical data cleaningSAE narrative generationmedical AIAI clinical assistantdrug development softwarelarge language modelsLLMs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octozi Comps

Public and private peers based on sector, stage, and business model.

Octozi comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Octozi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 7, 2026
Pre SeedJun 10, 2025

Key People

Founding team and executive leadership

Matt Purri

Chief Technology Officer, Co-Founder

Founding Team

Octozi Investors

Notable investors and investment history

Octozi investors
InvestorRounds
Surface VenturesSeed
DayOnePre Seed
Remarkable VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2026

    $3M round led by Surface Ventures

  • Jun 10, 2025

    Secured funding from Debiopharm Innovation Fund and DayOne.

Octozi Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Octozi Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Octozi's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2023
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.